BRPI0921843A2 - composição de vacina, par de oligonucleotídeo iniciador de reação em cadeia da polimerase. e métodos de imunizar um peru contra a coccidiose e de identificar um isolado de eimeria como e. meleagrimitis 2, e. meleagrimitis 2 em uma amostra biológica e as espécies de eimeria patogênica no peru presente em uma amostra biológica - Google Patents

composição de vacina, par de oligonucleotídeo iniciador de reação em cadeia da polimerase. e métodos de imunizar um peru contra a coccidiose e de identificar um isolado de eimeria como e. meleagrimitis 2, e. meleagrimitis 2 em uma amostra biológica e as espécies de eimeria patogênica no peru presente em uma amostra biológica

Info

Publication number
BRPI0921843A2
BRPI0921843A2 BRPI0921843A BRPI0921843A BRPI0921843A2 BR PI0921843 A2 BRPI0921843 A2 BR PI0921843A2 BR PI0921843 A BRPI0921843 A BR PI0921843A BR PI0921843 A BRPI0921843 A BR PI0921843A BR PI0921843 A2 BRPI0921843 A2 BR PI0921843A2
Authority
BR
Brazil
Prior art keywords
meleagrimitis
biological sample
turkey
eimeria
immunizing
Prior art date
Application number
BRPI0921843A
Other languages
English (en)
Inventor
Louise Mcgowan Alexandria
Saman Kumara Withanage Gamini
M Cook Stephanie
Hewart Fitz-Coy Steve
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of BRPI0921843A2 publication Critical patent/BRPI0921843A2/pt
Publication of BRPI0921843B1 publication Critical patent/BRPI0921843B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6893Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/002Protozoa antigens
    • A61K39/012Coccidia antigens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455Eimeria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/70Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in livestock or poultry

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI0921843-2A 2008-11-13 2009-11-11 composição de vacina, e, uso de uma composição de vacina BRPI0921843B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11420808P 2008-11-13 2008-11-13
US61/114,208 2008-11-13
PCT/US2009/063977 WO2010056709A2 (en) 2008-11-13 2009-11-11 Eimeria vaccine for turkeys

Publications (2)

Publication Number Publication Date
BRPI0921843A2 true BRPI0921843A2 (pt) 2018-10-09
BRPI0921843B1 BRPI0921843B1 (pt) 2020-11-24

Family

ID=41786412

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0921843-2A BRPI0921843B1 (pt) 2008-11-13 2009-11-11 composição de vacina, e, uso de uma composição de vacina

Country Status (8)

Country Link
US (1) US8252292B2 (pt)
EP (1) EP2355844A2 (pt)
AU (1) AU2009314192A1 (pt)
BR (1) BRPI0921843B1 (pt)
CA (1) CA2743262C (pt)
CL (1) CL2011001097A1 (pt)
MX (1) MX2011005133A (pt)
WO (1) WO2010056709A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2725361C (en) * 2008-05-29 2017-05-16 Intervet International B.V. Coccidiosis vaccines
US9603915B2 (en) 2013-02-14 2017-03-28 The Board of Trustees of the University of Akansas Compositions and methods of enhancing immune responses to Eimeria or limiting Eimeria infection
BE1028702B1 (nl) * 2020-10-13 2022-05-16 Poulpharm Bvba Biobank en werkwijze voor het in stand houden van deze biobank
CN115927691B (zh) * 2022-08-01 2026-03-17 山西农业大学 一种检测鸡球虫的四重pcr引物组、试剂盒

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5649323A (en) * 1979-09-29 1981-05-02 Nisshin Flour Milling Co Ltd Coccidiostat
JPS5780325A (en) * 1980-09-05 1982-05-19 Nat Res Dev Coccidial disease vaccine
GB8326633D0 (en) 1983-08-04 1983-11-09 Unilever Plc Compositions
JP3020226B2 (ja) * 1986-08-18 2000-03-15 ブリティッシュ・テクノロジー・グループ・リミテッド ワクチン
US4935007A (en) * 1986-08-28 1990-06-19 Eli Lilly And Company Anticoccidial method
KR960003379B1 (ko) 1986-08-28 1996-03-09 일라이 릴리 앤드 캄파니 개선된 콕시듐증 예방법
GB8711256D0 (en) * 1987-05-13 1987-06-17 Unilever Plc Protection
ZA954785B (en) * 1994-06-16 1996-02-08 Yamanouchi Pharma Co Ltd Crude drug-containing feed
FI974439A7 (fi) * 1995-06-07 1998-01-27 Pfizer In ovo-rokotus kokkidioosista vastaan
MX9709870A (es) * 1995-06-07 1998-03-31 Pfizer Uso de esporocistos u occistos para preparar una vacuna contra coccidiosis.
CA2213385A1 (en) 1997-08-20 1999-02-20 Eng-Hong Lee Method of protecting against coccidiosis infections in poultry
CA2214233A1 (en) * 1997-08-29 1999-02-28 Eng-Hong Lee Method for assessing viability of live microbial therapeutic agents
AUPP268398A0 (en) * 1998-03-30 1998-04-23 Eimeria Pty Limited Vaccination modalitites
DE19828322A1 (de) 1998-06-25 1999-12-30 Hoechst Roussel Vet Gmbh Coccidienvakzine, Verfahren zu ihrer Herstellung und ihre Verwendung
US7247309B2 (en) * 1999-12-21 2007-07-24 Intervet International B.V. Coccidiosis vaccines
AUPQ622900A0 (en) 2000-03-15 2000-04-06 University Of Melbourne, The Pcr-based identification of eimeria species and strains
US6432646B1 (en) * 2000-03-16 2002-08-13 The University Of Melbourne PCR-based identification of Eimeria species and strains
CA2428110A1 (en) 2000-11-08 2002-05-16 Novus International, Inc. Methods and compositions for the control of coccidiosis
US6969602B1 (en) * 2001-04-20 2005-11-29 The United States Of America As Represented By The Secretary Of The Agriculture Production of an immunovariant strain of Eimeria maxima contributes to strain cross-protection with other Eimeria maximas
WO2003020917A1 (en) * 2001-08-30 2003-03-13 Embrex, Inc. Improved methods for producing oocysts
TWI348376B (en) 2002-02-26 2011-09-11 Wyeth Corp Selection of poultry eimeria strains through extra-intestinal sporozites
US7250286B2 (en) * 2002-05-21 2007-07-31 Schering-Plough Corporation Methods for the in vitro culture of Sporozoea sp. and uses thereof
BR0313994A (pt) 2002-09-20 2005-07-19 Akzo Nobel Nv Parasita vivo atenuado, vacina para combater infecção parasìtica, uso de um parasita vivo atenuado, método para a produção de uma vacina, e, fragmento de dna
ATE483471T1 (de) * 2002-12-09 2010-10-15 Univ Georgia Kokzidioseimpfstoff sowie verfahren zu seiner herstellung und verwendung
US7354593B2 (en) 2002-12-09 2008-04-08 Merial Limited Coccidial vaccine and methods of making and using same
DK1742656T3 (da) 2004-03-12 2010-07-19 Univ Georgia Hidtil ukendt jordnøddeskindekstrakt som adjuvansvaccine
CA2464522C (en) * 2004-04-15 2011-11-15 Eng-Hong Lee Soft gel delivery system for treating poultry
US20080131463A1 (en) * 2006-11-30 2008-06-05 Perdue Holdings, Inc. Vaccination method for controlling coccidiosis in fowl
CA2725361C (en) 2008-05-29 2017-05-16 Intervet International B.V. Coccidiosis vaccines

Also Published As

Publication number Publication date
WO2010056709A2 (en) 2010-05-20
AU2009314192A1 (en) 2010-05-20
CA2743262A1 (en) 2010-05-20
MX2011005133A (es) 2011-08-04
EP2355844A2 (en) 2011-08-17
US20100166803A1 (en) 2010-07-01
BRPI0921843B1 (pt) 2020-11-24
CL2011001097A1 (es) 2012-07-20
CA2743262C (en) 2021-11-02
AU2009314192A2 (en) 2011-06-23
WO2010056709A3 (en) 2010-07-01
US8252292B2 (en) 2012-08-28

Similar Documents

Publication Publication Date Title
CY1125029T1 (el) Τροποποιημενοι νουκλεοζιτες, νουκλεοτιδια, και νουκλεϊκα οξεα και χρησεις αυτων
EP2569453A4 (en) Nucleic Acid ISOLATION METHOD
AR090465A1 (es) Formas solidas de un profarmaco de nucleotidos de tiofosforamidato
PH12015501423A1 (en) Substituted nucleosides, nucleotides and analogs thereof
ECSP12011685A (es) Inmunoconjugados dirigidos
BRPI0909820A2 (pt) Processo para estabilização de composição de vacina contra gripe, para estabilização de composição de vacina contendo adjuvante e para preparação de vacina, composições de vacina, kit de vacina e método de estocagem de uma matéria prima
EA201400170A1 (ru) Композиции и способы для ингибирования экспрессии транстиретина
MX2018006658A (es) Nucleosidos sustituidos, nucleotidos y analogos de los mismos.
WO2013101783A3 (en) Methods and compositions for performing nucleic acid amplification reactions
BRPI0922122A2 (pt) composições e métodos para tratamento de doença celíaca.
WO2009121032A3 (en) Sample preparation devices and methods for processing analytes
EP2321430B8 (en) Method of evaluating oral cancer risk in human
ES2721424T3 (es) Método de diagnóstico del cáncer de vejiga
HK1216535A1 (zh) 取代的核苷、核苷酸及其類似物
EA200970695A1 (ru) Способы и нуклеиновые кислоты для анализов нарушений клеточной пролиферации
SG10201605663UA (en) Improved quenching methods for red blood cell pathogen inactivation
BRPI0812771A2 (pt) Método para a detecção e diagnóstico in vitro de uma infecção por um microorganismo, conjunto de reagentes para a realização do método de detecção .
WO2010111503A3 (en) RNA INTERFERENCE MEDIATED INHIBITION OF THE HIGH AFFINITY IGE RECEPTOR ALPHA CHAIN (FCεRLα) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
WO2012166626A8 (en) Reagents and methods for treating dental disease
BR112014032892A2 (pt) processo de amplificação por rcp e de detecção de pelo menos uma sequência-alvo nucleotídica, dispositivo de amplificação e de detecção rápida de pelo menos uma sequência-alvo nucleotídica e estojo de amplificação por rcp e de detecção de pelo menos uma sequência nucleotídica-alvo
AU2013228077B2 (en) Composition for hot-start reverse transcription reaction or hot-start reverse transcription polymerase chain reaction
BRPI0922735A2 (pt) produção de alcoóis de cadeia ramificada através de micro-organismos fotossintéticos.
IN2014CN03921A (pt)
EA201301336A1 (ru) Лечение рака комбинацией молекул днк, имитирующих двухнитевые разрывы, и гипертермии
BRPI1014222A2 (pt) composto, composição farmacêutica,e, métodos para tratar distúrbio(s) cognitivo(s) ou indicações com déficit(s) na cognição, mal de alzheimer, e distúrbio bipolar

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 24/11/2020, OBSERVADAS AS CONDICOES LEGAIS.